loadpatents
name:-0.36931681632996
name:-0.099577188491821
name:-0.035890102386475
Umana; Pablo Patent Filings

Umana; Pablo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Umana; Pablo.The latest application filed is for "anti-fap antibodies and methods of use".

Company Profile
39.121.200
  • Umana; Pablo - Schlieren CH
  • UMANA; Pablo - Waedenswil CH
  • UMANA; Pablo - Wollerau CH
  • UMANA; Pablo - Schlieren-Zuerich CH
  • UMANA; Pablo - Zurich CH
  • Umana; Pablo - Zuerich CH
  • Umana; Pablo - Manchester N/A GB
  • Umana; Pablo - Wadenswil N/A CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bispecific antigen binding molecule for a costimulatory TNF receptor
Grant 11,453,722 - Amann , et al. September 27, 2
2022-09-27
Bispecific antigen binding molecules comprising anti-4-1BB clone 20H4.9
Grant 11,447,558 - Ferrara Koller , et al. September 20, 2
2022-09-20
Anti-fap Antibodies And Methods Of Use
App 20220281995 - BACAC; Marina ;   et al.
2022-09-08
Protease-activated T Cell Bispecific Molecules
App 20220275087 - BRUENKER; Peter ;   et al.
2022-09-01
Fusion Of An Antibody Binding Cea And 4-1bbl
App 20220267464 - Ferrara Koller; Claudia ;   et al.
2022-08-25
Antibodies Which Bind To Cancer Cells And Target Radionuclides To Said Cells
App 20220267463 - UMANA; Pablo ;   et al.
2022-08-25
Antigen Binding Molecules Comprising A Trimeric Tnf Family Ligand
App 20220267395 - Amann; Maria ;   et al.
2022-08-25
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer
App 20220259326 - Amann; Maria ;   et al.
2022-08-18
Bispecific Antibodies Specific For Pd1 And Tim3
App 20220259314 - CODARRI-DEAK; LAURA ;   et al.
2022-08-18
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer
App 20220259327 - Amann; Maria ;   et al.
2022-08-18
Immunoconjugates
Grant 11,413,331 - Codarri Deak , et al. August 16, 2
2022-08-16
Novel Immunoconjugates
App 20220242971 - AST; Oliver ;   et al.
2022-08-04
Bispecific Antigen Binding Molecules Comprising Anti-fap Clone 212
App 20220227878 - BRUENKER; Peter ;   et al.
2022-07-21
T Cell Activating Bispecific Antigen Binding Molecules
App 20220220224 - BACAC; Marina ;   et al.
2022-07-14
T Cell Activating Bispecific Antigen Binding Molecules
App 20220213224 - KLEIN; Christian ;   et al.
2022-07-07
Interleukin-2 fusion proteins and uses thereof
Grant 11,365,232 - Hosse , et al. June 21, 2
2022-06-21
Method for the determination of anti-drug antibodies against an effector function suppressed human or humanized drug antibody
Grant 11,340,234 - Umana , et al. May 24, 2
2022-05-24
Anti-FAP antibodies and methods of use
Grant 11,332,545 - Bacac , et al. May 17, 2
2022-05-17
Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer
Grant 11,306,154 - Amann , et al. April 19, 2
2022-04-19
Novel Icos Antibodies And Tumor-targeted Antigen Binding Molecules Comprising Them
App 20220098305 - DENGL; Stefan ;   et al.
2022-03-31
Combination therapy of PD-1-targeted IL-2 variant immunocytokines and antibodies against human PD-L1
App 20220072103 - CODARRI DEAK; Laura ;   et al.
2022-03-10
Bispecific Antibodies With Tetravalency For A Costimulatory Tnf Receptor
App 20220073646 - AMANN; Maria ;   et al.
2022-03-10
Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer
Grant 11,267,903 - Amann , et al. March 8, 2
2022-03-08
Bispecific T Cell Activating Antigen Binding Molecules
App 20220064296 - BACAC; Marina ;   et al.
2022-03-03
Treatment Method
App 20220054635 - BACAC; Marina ;   et al.
2022-02-24
Protease-activated T cell bispecific molecules
Grant 11,242,390 - Bruenker , et al. February 8, 2
2022-02-08
Bispecific antigen binding molecules comprising anti-FAP clone 212
Grant 11,242,396 - Bruenker , et al. February 8, 2
2022-02-08
Antibodies For Chelated Radionuclides And Clearing Agents
App 20220031871 - TORGUE; Julien ;   et al.
2022-02-03
Bispecific Antigen Binding Molecules Targeting Ox40 And Fap
App 20220025046 - AMANN; Maria ;   et al.
2022-01-27
Bispecific Antigen Binding Molecules Comprising Lipocalin Muteins
App 20220025069 - CLAUS; Christina ;   et al.
2022-01-27
Agonistic Cd28 Antigen Binding Molecules Targeting Her2
App 20220017637 - GASSER; Stephan ;   et al.
2022-01-20
Activatable Bispecific Antibodies
App 20220017640 - BRINKMANN; Ulrich ;   et al.
2022-01-20
Antibodies Binding To Cd3
App 20220010015 - CARPY GUTIERREZ CIRLOS; Alejandro ;   et al.
2022-01-13
Antibodies binding to CD3 and CD19
App 20220010014 - Freimoser-Grundschober; Anne ;   et al.
2022-01-13
Anti-cea Antibodies
App 20220002441 - Hofer; Thomas U. ;   et al.
2022-01-06
Antibodies specific for DR5 and methods of use
Grant 11,214,622 - Bruenker , et al. January 4, 2
2022-01-04
Antibodies Binding To Cd3
App 20210403562 - FREIMOSER-GRUNDSCHOBER; Anne ;   et al.
2021-12-30
Antibodies binding to HLA-A2/WT1
Grant 11,192,957 - Benz , et al. December 7, 2
2021-12-07
Aspgr Antibodies And Uses Thereof
App 20210324085 - Hofer; Thomas ;   et al.
2021-10-21
Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety
Grant 11,149,083 - Amann , et al. October 19, 2
2021-10-19
Bispecific antibodies specific for PD1 and TIM3
Grant 11,130,810 - Codarri-Deak , et al. September 28, 2
2021-09-28
Immunoconjugates
Grant 11,130,822 - Ast , et al. September 28, 2
2021-09-28
Bispecific Antigen Binding Molecules With Trivalent Binding To Cd40
App 20210292426 - DUERR; Harald ;   et al.
2021-09-23
Bispecific T cell activating antigen binding molecules
Grant 11,117,965 - Ast , et al. September 14, 2
2021-09-14
Mutant interleukin-2 polypeptides
Grant 11,111,312 - Ast , et al. September 7, 2
2021-09-07
Interleukin-2 fusion proteins and uses thereof
Grant 11,098,099 - Klein , et al. August 24, 2
2021-08-24
Treatment Method
App 20210252144 - BACAC; Marina ;   et al.
2021-08-19
Bispecific T Cell Activating Antigen Binding Molecules
App 20210253703 - BACAC; Marina ;   et al.
2021-08-19
Bispecific T Cell Activating Antigen Binding Molecules
App 20210253704 - BACAC; Marina ;   et al.
2021-08-19
Novel Bispecific Agonistic 4-1bb Antigen Binding Molecules
App 20210253724 - CLAUS; Christina ;   et al.
2021-08-19
Antibodies binding to HLA-A2/MAGE-A4
App 20210230278 - Weinzierl; Tina ;   et al.
2021-07-29
Novel Bispecific Antigen Binding Molecules Capable Of Specific Binding To Cd40 And To Fap
App 20210188992 - BRUENKER; Peter ;   et al.
2021-06-24
Therapeutic Combination Of 4-1 Bb Agonists With Anti-cd20 Antibodies
App 20210163617 - FERRARA KOLLER; Claudia ;   et al.
2021-06-03
Treatment method
Grant 11,013,801 - Bacac , et al. May 25, 2
2021-05-25
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
App 20210138065 - KLEIN; Christian ;   et al.
2021-05-13
ASPGR antibodies and uses thereof
Grant 10,975,151 - Hofer , et al. April 13, 2
2021-04-13
Bispecific T Cell Activating Antigen Binding Molecules
App 20210101979 - BACAC; Marina ;   et al.
2021-04-08
Combination Therapy With Targeted 4-1bb (cd137) Agonists
App 20210095002 - CLAUS; Christina ;   et al.
2021-04-01
Combination Therapy Of T Cell Activating Bispecific Antigen Binding Molecules And Pd-1 Axis Binding Antagonists
App 20210087291 - KLEIN; Christian ;   et al.
2021-03-25
Method For The Selection Of Antibodies Against Bcma
App 20210070873 - VU; Minh Diem ;   et al.
2021-03-11
Bispecific T Cell Activating Antigen Binding Molecules
App 20210070882 - BACAC; Marina ;   et al.
2021-03-11
Stabilized Immunoglobulin Domains
App 20210054021 - Deak Codarri; Laura ;   et al.
2021-02-25
Antibodies binding to NKG2D
App 20210032349 - DENGL; Stefan ;   et al.
2021-02-04
Her2-targeting Antigen Binding Molecules Comprising 4-1bbl
App 20210024610 - FERRARA KOLLER; Claudia ;   et al.
2021-01-28
C-terminally Fused Tnf Family Ligand Trimer-containing Antigen Binding Molecules
App 20210009656 - BRUENKER; Peter ;   et al.
2021-01-14
Antigen Binding Molecules With Increased Fc Receptor Binding Affinity And Effector Function
App 20210002382 - UMANA; Pablo ;   et al.
2021-01-07
Combination therapy with targeted OX40 agonists
App 20200392237 - BACAC; Marina ;   et al.
2020-12-17
Bispecific T Cell Activating Antigen Binding Molecules
App 20200385470 - BACAC; Marina ;   et al.
2020-12-10
Methods Of Treating Cea-positive Cancers Using Pd-1 Axis Binding Antagonists And Anti-cea/anti-cd3 Bispecific Antibodies
App 20200376119 - BACAC; Marina ;   et al.
2020-12-03
Method for the selection of antibodies against BCMA
Grant 10,851,171 - Vu , et al. December 1, 2
2020-12-01
Bispecific Antibodies Comprising An Antigen-binding Site Binding To Lag3
App 20200354457 - Codarri Deak; Laura ;   et al.
2020-11-12
Bispecific T Cell Activating Antigen Binding Molecules
App 20200347147 - BACAC; Marina ;   et al.
2020-11-05
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
App 20200332012 - UMANA; Pablo ;   et al.
2020-10-22
Combination Therapy With Targeted 4-1bb (cd137) Agonists
App 20200325225 - BACAC; Marina ;   et al.
2020-10-15
Combination Therapy Of Anti-cd20/anti-cd3 Bispecific Antibodies And 4-1bb (cd137) Agonists
App 20200325238 - BACAC; Marina ;   et al.
2020-10-15
Combination Therapy Of Tumor Targeted Icos Agonists With T-cell Bispecific Molecules
App 20200306373 - BACAC; Marina ;   et al.
2020-10-01
Bispecific T cell activating antigen binding molecules
Grant 10,781,257 - Bacac , et al. Sept
2020-09-22
Bispecific T cell activating antigen binding molecules
Grant 10,781,258 - Bacac , et al. Sept
2020-09-22
Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists
Grant 10,781,262 - Klein , et al. Sept
2020-09-22
Bispecific Her2 Antibodies And Methods Of Use
App 20200291131 - Croasdale-Wood; Rebecca ;   et al.
2020-09-17
Monoclonal Antibodies Against Bcma
App 20200283545 - Vu; Minh Diem ;   et al.
2020-09-10
Bispecific T cell activating antigen binding molecules
Grant 10,766,967 - Bacac , et al. Sep
2020-09-08
Bispecific Antigen Binding Molecule For A Costimulatory Tnf Receptor
App 20200277392 - AMANN; Maria ;   et al.
2020-09-03
Antigen Binding Molecules Comprising A Trimeric Tnf Family Ligand
App 20200270321 - Amann; Maria ;   et al.
2020-08-27
Antibodies Binding To Cd3
App 20200270347 - FREIMOSER-GRUNDSCHOBER; Anne ;   et al.
2020-08-27
Modified anti-tenascin antibodies and methods of use
Grant 10,745,470 - Hosse , et al. A
2020-08-18
Bispecific Antibodies Against Cd3epsilon And Ror1
App 20200255521 - Kind Code
2020-08-13
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer
App 20200247904 - Kind Code
2020-08-06
Bispecific Antigen Binding Molecule For A Costimulatory Tnf Receptor
App 20200231691 - GRAU-RICHARDS; Sandra ;   et al.
2020-07-23
Bispecific T Cell Activating Antigen Binding Molecules
App 20200231673 - AST; Oliver ;   et al.
2020-07-23
Tumor-targeted Superagonistic Cd28 Antigen Binding Molecules
App 20200223925 - GASSER; Stephan ;   et al.
2020-07-16
Combination Il-2 Immunoconjugate Therapy
App 20200197492 - GERDES; Christian ;   et al.
2020-06-25
Tumor-targeted Agonistic Cd28 Antigen Binding Molecules
App 20200199234 - GEORGES; Guy ;   et al.
2020-06-25
Interleukin-2 Immunoconjugate, A Cd40 Agonist, And Optionally A Pd-1 Axis Binding Antagonist For Use In Methods Of Treating Canc
App 20200188526 - KLEIN; Christian ;   et al.
2020-06-18
Bispecific Antigen Binding Molecules Comprising Anti-4-1bb Clone 20h4.9
App 20200190206 - FERRARA KOLLER; Claudia ;   et al.
2020-06-18
Bispecific antigen binding molecules comprising anti-FAP clone 212
App 20200190207 - BRUENKER; Peter ;   et al.
2020-06-18
Monoclonal antibodies against BCMA
Grant 10,683,369 - Vu , et al.
2020-06-16
Interleukin-2 Fusion Proteins And Uses Thereof
App 20200172591 - Hosse; Ralf ;   et al.
2020-06-04
Common Light Chains And Methods Of Use
App 20200172633 - KLEIN; Christian ;   et al.
2020-06-04
Type Ii Anti-cd20 Antibody And Anti-cd20/cd3 Bispecific Antibody For Treatment Of Cancer
App 20200172627 - BACAC; Marina ;   et al.
2020-06-04
Bispecific T cell activating antigen binding molecules
Grant 10,611,840 - Ast , et al.
2020-04-07
Bispecific T cell activating antigen binding molecules
Grant 10,611,841 - Ast , et al.
2020-04-07
Aspgr Antibodies And Uses Thereof
App 20200102392 - Hofer; Thomas ;   et al.
2020-04-02
Combination IL-2 immunoconjugate therapy
Grant 10,603,360 - Gerdes , et al.
2020-03-31
Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodies
Grant 10,596,257 - Bacac , et al.
2020-03-24
Anti-fap Antibodies And Methods Of Use
App 20200079873 - BACAC; Marina ;   et al.
2020-03-12
Bispecific HER2 antibodies and methods of use
Grant 10,584,178 - Croasdale-Wood , et al.
2020-03-10
Bispecific Antibodies Specific For Ox40
App 20200071411 - AMANN; Maria ;   et al.
2020-03-05
Anti-FAP antibodies and methods of use
Grant 10,577,429 - Bacac , et al.
2020-03-03
Trivalent, Bispecific Antibodies
App 20200062826 - BRINKMANN; Ulrich ;   et al.
2020-02-27
Interleukin-2 fusion proteins and uses thereof
Grant 10,562,949 - Hosse , et al. Feb
2020-02-18
Bispecific antibodies specific for OX40
Grant 10,526,413 - Amann , et al. J
2020-01-07
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer
App 20190382507 - Amann; Maria ;   et al.
2019-12-19
Combination Therapy Of Tumor-targeted Il-2 Variant Immunocytokines And Antibodies Against Human Pd-l1
App 20190374609 - Umana; Pablo ;   et al.
2019-12-12
Monoclonal Antibodies Against Bcma
App 20190352427 - Vu; Minh Diem ;   et al.
2019-11-21
Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules
Grant 10,464,981 - Amann , et al. No
2019-11-05
Novel Immunoconjugates
App 20190322763 - AST; Oliver ;   et al.
2019-10-24
Bispecific Antibodies Specific For Pd1 And Tim3
App 20190322748 - CODARRI-DEAK; LAURA ;   et al.
2019-10-24
Mutant Interleukin-2 Polypeptides
App 20190322765 - Ast; Oliver ;   et al.
2019-10-24
Novel Immunoconjugates
App 20190315883 - AST; Oliver ;   et al.
2019-10-17
Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules
Grant 10,392,445 - Amann , et al. A
2019-08-27
Antibodies binding To HLA-A2/WT1
App 20190248916 - Benz; Joerg ;   et al.
2019-08-15
Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety
App 20190248877 - Amann; Maria ;   et al.
2019-08-15
A-fucosylation detection in antibodies
Grant 10,352,943 - Jaeger , et al. July 16, 2
2019-07-16
Bispecific Antibodies With Tetravalency For A Costimulatory Tnf Receptor
App 20190211113 - AMANN; Maria ;   et al.
2019-07-11
C-terminally Fused Tnf Family Ligand Trimer-containing Antigen Binding Molecules
App 20190194291 - Bruenker; Peter ;   et al.
2019-06-27
Anti-cea Antibodies
App 20190185583 - Hofer; Thomas U. ;   et al.
2019-06-20
Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moiety
App 20190185566 - Koller; Claudia Ferrara ;   et al.
2019-06-20
Mutant interleukin-2 polypeptides
Grant 10,323,098 - Ast , et al.
2019-06-18
Bispecific T Cell Activating Antigen Binding Molecules
App 20190177413 - BACAC; Marina ;   et al.
2019-06-13
Immunoconjugates
Grant 10,316,104 - Ast , et al.
2019-06-11
Removal Of Cancer Cells By Circulating Virus-specific Cytotoxic T-cells Using Cancer Cell Targeted Mhc Class 1 Compromising Mult
App 20190169309 - Klein; Christian ;   et al.
2019-06-06
Modified Anti-tenascin Antibodies And Methods Of Use
App 20190169277 - HOSSE; Ralf ;   et al.
2019-06-06
Bispecific antibodies specific for PD1 and TIM3
Grant 10,287,352 - Codarri-Deak , et al.
2019-05-14
Protease-activated T Cell Bispecific Molecules
App 20190119383 - BRUENKER; Peter ;   et al.
2019-04-25
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
App 20190106497 - Umana; Pablo ;   et al.
2019-04-11
Bispecific antibodies against CD3 and BCMA
Grant 10,253,104 - Vu , et al.
2019-04-09
Anti-FAP antibodies and methods of use
Grant 10,253,110 - Bacac , et al.
2019-04-09
Mutant Interleukin-2 Polypeptides
App 20190077881 - Ast; Oliver ;   et al.
2019-03-14
Bispecific Antibodies Specific For Fap And Dr5, Antibodies Specific For Dr5 And Methods Of Use
App 20190062453 - Bruenker; Peter ;   et al.
2019-02-28
Immunoconjugates
Grant 10,202,464 - Ast , et al. Feb
2019-02-12
T Cell Activating Bispecific Antigen Binding Molecules
App 20190031784 - Bacac; Marina ;   et al.
2019-01-31
Aspgr Antibodies And Uses Thereof
App 20190031760 - HOFER; Thomas ;   et al.
2019-01-31
Mutant interleukin-2 polypeptides
Grant 10,184,009 - Ast , et al. Ja
2019-01-22
Trimeric Costimulatory Tnf Family Ligand-containing Antigen Binding Molecules
App 20190016771 - AMANN; Maria ;   et al.
2019-01-17
Bispecific T Cell Activating Antigen Binding Molecules
App 20190002565 - BACAC; Marina ;   et al.
2019-01-03
Bispecific T Cell Activating Antigen Binding Molecules
App 20190002564 - BACAC; Marina ;   et al.
2019-01-03
Bispecific T cell activating antigen binding molecules
Grant 10,155,815 - Bacac , et al. Dec
2018-12-18
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
App 20180344848 - Klein; Christian ;   et al.
2018-12-06
Novel Bispecific Antigen Binding Molecules Capable Of Specific Binding To Cd40 And To Fap
App 20180340030 - BRUENKER; Peter ;   et al.
2018-11-29
Immunoconjugates
App 20180326010 - Codarri Deak; Laura ;   et al.
2018-11-15
Immunoconjugates
App 20180326011 - Codarri Deak; Laura ;   et al.
2018-11-15
Bispecific T Cell Activating Antigen Binding Molecules
App 20180312589 - BACAC; Marina ;   et al.
2018-11-01
Bispecific antibodies
Grant 10,106,600 - Brinkmann , et al. October 23, 2
2018-10-23
Trivalent, Bispecific Antibodies
App 20180282399 - BRINKMANN; Ulrich ;   et al.
2018-10-04
Anti-cd3xrob04 Bispecific T Cell Activating Antigen Binding Molecules
App 20180282410 - AST; Oliver ;   et al.
2018-10-04
Fc-free antibodies comprising two fab-fragments and methods of use
Grant 10,087,250 - Bruenker , et al. October 2, 2
2018-10-02
ASPGR antibodies and uses thereof
Grant 10,087,254 - Hofer , et al. October 2, 2
2018-10-02
Bispecific T Cell Activating Antigen Binding Molecules
App 20180273643 - AST; Oliver ;   et al.
2018-09-27
Separation Method For Fucosylated Antibodies
App 20180265544 - Freimoser-Grundschober; Anne ;   et al.
2018-09-20
Bispecific antibodies against CD3 and BCMA
Grant 10,077,315 - Vu , et al. September 18, 2
2018-09-18
Bispecific T Cell Activating Antigen Binding Molecules
App 20180222981 - AST; Oliver ;   et al.
2018-08-09
Method For The Selection Of Antibodies Against Bcma
App 20180222991 - VU; Minh Diem ;   et al.
2018-08-09
Bispecific T Cell Activating Antigen Binding Molecules
App 20180222980 - AST; Oliver ;   et al.
2018-08-09
Interleukin-10 fusion proteins and uses thereof
Grant 10,040,843 - Duerner , et al. August 7, 2
2018-08-07
Combination Therapy Of Tumor-targeted Il-2 Variant Immunocytokines And Antibodies Against Human Pd-l1
App 20180200338 - Umana; Pablo ;   et al.
2018-07-19
Separation method for fucosylated antibodies
Grant 9,994,610 - Freimoser-Grundschober , et al. June 12, 2
2018-06-12
Mutant Interleukin-2 Polypeptides
App 20180142037 - AST; Oliver ;   et al.
2018-05-24
Trimeric antigen binding molecules
Grant 9,975,958 - Bruenker , et al. May 22, 2
2018-05-22
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
App 20180133315 - Klein; Christian ;   et al.
2018-05-17
Method for the selection of antibodies against BCMA
Grant 9,963,513 - Vu , et al. May 8, 2
2018-05-08
Aspgr Antibodies And Uses Thereof
App 20180118833 - HOFER; Thomas ;   et al.
2018-05-03
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 9,957,326 - Umana , et al. May 1, 2
2018-05-01
Bispecific T Cell Activating Antigen Binding Molecules
App 20180086849 - Bacac; Marina ;   et al.
2018-03-29
Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5
Grant 9,926,379 - Bruenker , et al. March 27, 2
2018-03-27
Anti-cea Antibodies
App 20180079827 - Hofer; Thomas U. ;   et al.
2018-03-22
Bispecific T cell activating antigen binding molecules
Grant 9,914,776 - Ast , et al. March 13, 2
2018-03-13
Trivalent, bispecific antibodies
Grant 9,890,204 - Brinkmann , et al. February 13, 2
2018-02-13
Interleukin-2 Fusion Proteins And Uses Thereof
App 20180009868 - Hosse; Ralf ;   et al.
2018-01-11
Methods Of Treating Cea-positive Cancers Using Pd-1 Axis Binding Antagonists And Anti-cea/anti-cd3 Bispecific Antibodies
App 20180000931 - Bacac; Marina ;   et al.
2018-01-04
Combination Therapy Of T Cell Activating Bispecific Antigen Binding Molecules And Pd-1 Axis Binding Antagonists
App 20170349666 - Klein; Christian ;   et al.
2017-12-07
Method For The Determination Of Anti-drug Antibodies Against An Effector Function Suppressed Human Or Humanized Drug Antibody
App 20170343560 - Umana; Pablo ;   et al.
2017-11-30
Bispecific Antibodies Against Cd3epsilon And Bcma
App 20170327579 - VU; MINH DIEM ;   et al.
2017-11-16
Bispecific Antibodies Against Cd3epsilon And Ror1
App 20170306018 - VU; MINH DIEM ;   et al.
2017-10-26
Bispecific Antibodies Against Cd3epsilon And Bcma
App 20170306036 - VU; Minh Diem ;   et al.
2017-10-26
Bispecific Antibodies Against Cd3epsilon And Ror1 For Use In The Treatment Of Ovarian Cancer
App 20170306044 - VU; MINH DIEM ;   et al.
2017-10-26
Combination Therapy Of An Afucosylated Cd20 Antibody With A Cd22 Antibody-drug Conjugate
App 20170306040 - Klein; Christian ;   et al.
2017-10-26
ASGPR antibodies and uses thereof
Grant 9,771,427 - Hofer , et al. September 26, 2
2017-09-26
Common Light Chains And Methods Of Use
App 20170253670 - Klein; Christian ;   et al.
2017-09-07
Bispecific Antibodies With Tetravalency For A Costimulatory Tnf Receptor
App 20170247467 - AMANN; MARIA ;   et al.
2017-08-31
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 9,718,885 - Umana , et al. August 1, 2
2017-08-01
Treatment Method
App 20170209573 - Bacac; Marina ;   et al.
2017-07-27
Bispecific Antigen Binding Molecules
App 20170198043 - Auer; Johannes ;   et al.
2017-07-13
Bispecific T Cell Activating Antigen Binding Molecules
App 20170190783 - Bacac; Marina ;   et al.
2017-07-06
METHOD AND CONSTRUCTS FOR THE pH DEPENDENT PASSAGE OF THE BLOOD-BRAIN-BARRIER
App 20170174776 - Bohrmann; Bernd ;   et al.
2017-06-22
Bispecific T Cell Activating Antigen Binding Molecules
App 20170174786 - Bacac; Marina ;   et al.
2017-06-22
Bispecific anti-EGFR/anti IGF-1R antibodies
Grant 9,650,442 - Hosse , et al. May 16, 2
2017-05-16
Bispecific Antibodies Specific For A Costimulatory Tnf Receptor
App 20170114141 - AMANN; MARIA ;   et al.
2017-04-27
Bispecific Antibodies Specific For Pd1 And Tim3
App 20170114135 - CODARRI-DEAK; LAURA ;   et al.
2017-04-27
Bispecific T cell activating antigen binding molecules
App 20170114146 - Klein; Christian ;   et al.
2017-04-27
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Grant 9,631,023 - Umana , et al. April 25, 2
2017-04-25
A-fucosylation Detection In Antibodies
App 20170108510 - Jaeger; Christiane ;   et al.
2017-04-20
Bispecific T Cell Activating Antigen Binding Molecules
App 20170096495 - BACAC; Marina ;   et al.
2017-04-06
Bispecific T Cell Activating Antigen Binding Molecules
App 20170096485 - BACAC; Marina ;   et al.
2017-04-06
Novel Immunoconjugates
App 20170088631 - Ast; Oliver ;   et al.
2017-03-30
Combination Il-2 Immunoconjugate Therapy
App 20170056522 - Gerdes; Christian ;   et al.
2017-03-02
Bispecific Her2 Antibodies And Methods Of Use
App 20170029529 - Croasdale; Rebecca ;   et al.
2017-02-02
Combination IL-2 immunoconjugate therapy
Grant 9,526,797 - Gerdes , et al. December 27, 2
2016-12-27
Interleukin-10 Fusion Proteins And Uses Thereof
App 20160340413 - Duerner; Lydia Jasmin ;   et al.
2016-11-24
Antigen Binding Molecules Comprising A Trimeric Tnf Family Ligand
App 20160340399 - Amann; Maria ;   et al.
2016-11-24
DR5--FAP bispecific death receptor agonistic antibodies
Grant 9,481,730 - Bruenker , et al. November 1, 2
2016-11-01
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
App 20160304614 - UMANA; Pablo ;   et al.
2016-10-20
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1
App 20160297881 - VU; Minh Diem ;   et al.
2016-10-13
Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
App 20160272719 - Umana; Pablo ;   et al.
2016-09-22
Immunoconjugates
Grant 9,447,159 - Ast , et al. September 20, 2
2016-09-20
Anti-tenascin-c A2 Antibodies And Methods Of Use
App 20160264651 - Freimoser-Grundschober; Anne ;   et al.
2016-09-15
Novel Immunoconjugates
App 20160263240 - Ast; Oliver ;   et al.
2016-09-15
Anti-cea Antibodies
App 20160229923 - Hofer; Thomas U. ;   et al.
2016-08-11
Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
App 20160208009 - Umana; Pablo ;   et al.
2016-07-21
T Cell Activating Bispecific Antigen Binding Molecules
App 20160208019 - BACAC; Marina ;   et al.
2016-07-21
Mutant Interleukin-2 Polypeptides
App 20160208017 - Ast; Oliver ;   et al.
2016-07-21
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer
App 20160200833 - Amann; Maria ;   et al.
2016-07-14
Multispecific antibodies comprising full length antibodies and single chain fab fragments
Grant 9,382,323 - Brinkmann , et al. July 5, 2
2016-07-05
Combination Therapy Of Tumor-targeted Il-2 Variant Immunocytokines And Antibodies Against Human Pd-l1
App 20160175397 - UMANA; Pablo ;   et al.
2016-06-23
Trimeric Antigen Binding Molecules
App 20160159917 - BRUENKER; Peter ;   et al.
2016-06-09
Predictive biomarker for cancer treatment with ADCC-enhanced antibodies
Grant 9,360,481 - Di Scala , et al. June 7, 2
2016-06-07
Bispecific T Cell Activating Antigen Binding Molecules
App 20160145354 - BACAC; MARINA ;   et al.
2016-05-26
Interleukin-10 fusion proteins
Grant 9,346,872 - Duerner , et al. May 24, 2
2016-05-24
Fc-free antibodies comprising two Fab-fragments and methods of use
App 20160130347 - Bruenker; Peter ;   et al.
2016-05-12
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Grant 9,321,843 - Umana , et al. April 26, 2
2016-04-26
Anti-MCSP antibodies
Grant 9,309,306 - Freytag , et al. April 12, 2
2016-04-12
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 9,309,317 - Umana , et al. April 12, 2
2016-04-12
Interleukin-2 Fusion Proteins And Uses Thereof
App 20160090407 - Hosse; Ralf ;   et al.
2016-03-31
Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function
Grant 9,296,820 - Umana , et al. March 29, 2
2016-03-29
Removal of Cancer Cells by Circulating Virus-Specific Cytotoxic T-Cells Using Cancer Cell Targeted MHC Class 1 Compromising Multi-Function Proteins
App 20160083477 - Klein; Christian ;   et al.
2016-03-24
ANTIGEN BINDING MOLECULES WITH INCREASED Fc RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION
App 20160075794 - UMANA; Pablo ;   et al.
2016-03-17
Bispecific T Cell Activating Antigen Binding Molecules
App 20160075785 - Ast; Oliver ;   et al.
2016-03-17
Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof
App 20160075795 - MOSSNER; Ekkehard ;   et al.
2016-03-17
ANTIGEN BINDING MOLECULES WITH INCREASED Fc RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION
App 20160075793 - UMANA; Pablo ;   et al.
2016-03-17
ANTIGEN BINDING MOLECULES WITH INCREASED Fc RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION
App 20160076009 - UMANA; Pablo ;   et al.
2016-03-17
In Vivo Adcc Model
App 20160058891 - Breustedt; Daniel ;   et al.
2016-03-03
Anti-fap Antibodies And Methods Of Use
App 20160060356 - Bacac; Marina ;   et al.
2016-03-03
Anti-fap Antibodies And Methods Of Use
App 20160060357 - Bacac; Marina ;   et al.
2016-03-03
Mutant interleukin-2 polypeptides
Grant 9,266,938 - Ast , et al. February 23, 2
2016-02-23
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Proteasome Inhibitor
App 20160000912 - FERTIG; GEORG ;   et al.
2016-01-07
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxity (adcc)
App 20160000911 - DUMONTET; CHARLES ;   et al.
2016-01-07
Bispecific Antibodies Against Cd3 And Bcma
App 20150376287 - VU; Minh Diem ;   et al.
2015-12-31
Method For The Selection Of Antibodies Against Bcma
App 20150368351 - VU; Minh Diem ;   et al.
2015-12-24
Anti-CEA antibodies
Grant 9,206,260 - Hofer , et al. December 8, 2
2015-12-08
Modified Antigen Binding Molecules With Altered Cell Signaling Activity
App 20150344584 - Umana; Pablo ;   et al.
2015-12-03
Asgpr Antibodies And Uses Thereof
App 20150299324 - Hofer; Thomas ;   et al.
2015-10-22
Anti-tenascin-C A2 antibodies and methods of use
Grant 9,156,913 - Freimoser-Grundschober , et al. October 13, 2
2015-10-13
Bispecific Antibodies Specific For T-cell Activating Antigens And A Tumor Antigen And Methods Of Use
App 20150274845 - Bruenker; Peter ;   et al.
2015-10-01
Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
App 20150274837 - UMANA; Pablo ;   et al.
2015-10-01
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 9,139,654 - Umana , et al. September 22, 2
2015-09-22
Interleukin-2 Fusion Proteins And Uses Thereof
App 20150218260 - Klein; Christian ;   et al.
2015-08-06
Interleukin-10 Fusion Proteins And Uses Thereof
App 20150218244 - Emrich; Thomas ;   et al.
2015-08-06
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 9,074,008 - Umana , et al. July 7, 2
2015-07-07
Antibodies to carcinoembryonic antigen (CEA), methods of making same, and uses thereof
Grant 9,068,008 - Mossner , et al. June 30, 2
2015-06-30
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 9,068,005 - Umana , et al. June 30, 2
2015-06-30
Anti-FAP antibodies and methods of use
Grant 9,011,847 - Bacac , et al. April 21, 2
2015-04-21
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Grant 8,999,324 - Umana , et al. April 7, 2
2015-04-07
Combination Therapy Of A Type Ii Anti-cd20 Antibody With An Anti-bcl-2 Active Agent
App 20150056186 - FRIESS; THOMAS ;   et al.
2015-02-26
Targeted immunoconjugates
Grant 8,945,571 - Mossner , et al. February 3, 2
2015-02-03
Combination Therapy Of An Afucosylated Cd20 Antibody With A Cd22 Antibody-drug Conjugate
App 20150010540 - Klein; Christian ;   et al.
2015-01-08
Bispecific Antibodies Specific For Fap And Dr5, Antibodies Specific For Dr5 And Methods Of Use
App 20140370019 - Bruenker; Peter ;   et al.
2014-12-18
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
App 20140356352 - Klein; Christian ;   et al.
2014-12-04
Antigen binding molecules with increased Fc receptor binding affinity and effector function
Grant 8,883,980 - Umana , et al. November 11, 2
2014-11-11
Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Grant 8,859,234 - Umana , et al. October 14, 2
2014-10-14
A-fucosylation Detection In Antibodies
App 20140302544 - Jaeger; Christiane ;   et al.
2014-10-09
Combination Therapy With Type I And Type Ii Anti-cd20 Antibodies
App 20140294807 - FRIESS; THOMAS ;   et al.
2014-10-02
Separation Method For Fucosylated Antibodies
App 20140255399 - Freimoser-Grundschober; Anne ;   et al.
2014-09-11
Bispecific T Cell Activating Antigen Binding Molecules
App 20140242080 - Jaeger; Christiane ;   et al.
2014-08-28
Bispecific T Cell Activating Antigen Binding Molecules
App 20140242079 - Bacac; Marina ;   et al.
2014-08-28
Predictive biomarker for cancer treatment with ADCC-enhanced antibodies
App 20140227256 - Di Scala; Lilla ;   et al.
2014-08-14
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
App 20140227253 - UMANA; Pablo ;   et al.
2014-08-14
Anti-CEA Antibodies
App 20140212408 - Hofer; Thomas U. ;   et al.
2014-07-31
Bispecific Anti-egfr/anti Igf-1r Antibodies
App 20140193415 - Hosse; Ralf ;   et al.
2014-07-10
Bispecific Anti ErbB3 / Anti cMet Antibodies
App 20140135482 - Bossenmaier; Birgit ;   et al.
2014-05-15
Fusion Constructs and Use of Same to Produce Antibodies with Increased Fc Receptor Binding Affinity and Effector Function
App 20140073005 - UMANA; PABLO ;   et al.
2014-03-13
Immunotherapy
App 20140072528 - Gerdes; Christian ;   et al.
2014-03-13
Immunotherapy
App 20140065097 - Gerdes; Christian ;   et al.
2014-03-06
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxity (adcc)
App 20140065134 - DUMONTET; CHARLES ;   et al.
2014-03-06
Anti-CEA antibodies
Grant 8,642,742 - Hofer , et al. February 4, 2
2014-02-04
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 8,629,248 - Umana , et al. January 14, 2
2014-01-14
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 8,623,644 - Umana , et al. January 7, 2
2014-01-07
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 8,614,065 - Umana , et al. December 24, 2
2013-12-24
Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Grant 8,367,374 - Umana , et al. February 5, 2
2013-02-05
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 8,273,328 - Umana , et al. September 25, 2
2012-09-25
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 8,097,436 - Umana , et al. January 17, 2
2012-01-17
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Grant 8,021,856 - Umana , et al. September 20, 2
2011-09-20
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 7,906,329 - Umana , et al. March 15, 2
2011-03-15
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 7,846,432 - Umana , et al. December 7, 2
2010-12-07
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 7,727,741 - Umana , et al. June 1, 2
2010-06-01
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 7,722,867 - Umana , et al. May 25, 2
2010-05-25
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 7,662,377 - Umana , et al. February 16, 2
2010-02-16
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 7,517,670 - Umana , et al. April 14, 2
2009-04-14
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 6,602,684 - Umana , et al. August 5, 2
2003-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed